Search filters

List of works by Arjun V Balar

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

scientific article

Atezolizumab in invasive and metastatic urothelial carcinoma.

scientific article

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

scientific article

BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma

scientific article published on 25 November 2019

Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma

scientific article published on 26 February 2019

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

scientific article published on 01 October 2018

Efficacy and Safety of Selective Vascular Endothelial Growth Factor Receptor Inhibitors Compared with Sorafenib for Metastatic Renal Cell Carcinoma: a Meta-analysis of Randomised Controlled Trials.

scientific article published on 24 December 2015

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer

scientific article published on 06 February 2019

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.

scientific article

High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma

scientific article published on 28 March 2019

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

scientific article published on June 1, 2011

Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development

scientific article published on 11 March 2015

Novel agents in invasive urothelial cancer

scientific article published on August 1, 2012

PD-1 and PD-L1 antibodies in cancer: current status and future directions

scientific article published on 17 February 2017

PD-1/PD-L1 Combinations in Advanced Urothelial Cancer: Rationale and Current Clinical Trials

scientific article published on 29 March 2019

PIVOT-10: Phase II study of bempegaldesleukin plus nivolumab in cisplatin-ineligible advanced urothelial cancer

scientific article published on 17 September 2020

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience

article

Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy

scientific article published on 29 July 2019

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

scientific article published on 19 August 2019

The impact of taxanes on the management of genitourinary cancers

scientific article published on May 2014